Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

NCT05714501 is registered in ClinicalTrials.gov with Perfuze as lead sponsor.

NCT NCT05714501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05714501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Millipede AspiRation for Revascularization in Stroke (MARRS) Study
Lead sponsor
Perfuze
Phase
Not applicable
Overall status
Completed
Start date
October 9, 2023
Completion date
May 12, 2025
Enrollment
235 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke